03/29/2024
3:11 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
1:20 PM | Eloxx Pharmaceuticals, Inc. (Subject)
Eloxx Pharmaceuticals (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
03/14/2024
3:30 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
8:44 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/09/2024
4:10 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
3:11 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
3:58 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2023
4:26 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2023
3:05 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2023
12:26 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 424B5 | |
09/18/2023
7:05 AM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
4:15 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
9:14 AM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2023
3:32 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2023
3:50 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
10:56 AM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
3:05 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/13/2023
7:43 AM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
8:15 AM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
7:32 PM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
7:40 AM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 424B5 | |
05/24/2023
7:07 AM | Eloxx Pharmaceuticals, Inc. (Filer)
Eloxx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
